At a glance
- Originator Glycomed
- Class Anti-ischaemics
- Mechanism of Action Selectin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ischaemic heart disorders
Most Recent Events
- 07 Feb 2001 Discontinued-Preclinical for Ischaemic heart disorders in USA (Unknown route)
- 26 Feb 1998 New profile
- 26 Feb 1998 Preclinical development for Ischaemic heart disorders in USA (Unknown route)